DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+6.55%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$199M
AUM Growth
+$199M
(+0.87%)
Cap. Flow
-$14.6M
Cap. Flow
% of AUM
-7.33%
Top 10 Holdings %
Top 10 Hldgs %
47.58%
Holding
102
New
10
Increased
16
Reduced
28
Closed
14
Top Buys
| 1 |
Pfizer
PFE
|
$1.96M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$1.95M |
| 3 |
KIN
Kindred Biosciences, Inc.
KIN
|
$1.48M |
| 4 |
Altimmune
ALT
|
$1.44M |
| 5 |
Ford
F
|
$1.34M |
Top Sells
| 1 |
iShares Gold Trust
IAU
|
$3.37M |
| 2 |
Oracle
ORCL
|
$3.31M |
| 3 |
AbbVie
ABBV
|
$2.82M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$2.02M |
| 5 |
AT&T
T
|
$1.87M |
Sector Composition
| 1 | Healthcare | 40.94% |
| 2 | Technology | 16.69% |
| 3 | Communication Services | 12.11% |
| 4 | Financials | 6.46% |
| 5 | Consumer Discretionary | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$2.58T
| $16.3M | 5.77% | 6,500 | – | – |
|
|
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $15.3M | 5.42% | 375,000 -49,500 | -12% | -$2.02M |
|
3
Micron Technology
MU
$133B
| $14.4M | 5.12% | 170,000 +10,000 | +6% | +$850K |
|
|
4
AbbVie
ABBV
$372B
| $8.67M | 3.07% | 77,000 -25,000 | -25% | -$2.82M |
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.66M | 3.07% | 15,500 +2,000 | +15% | +$1.12M |
|
6
Xencor
XNCR
$580M
| $6.8M | 2.41% | 197,000 +7,000 | +4% | +$241K |
|
|
7
VanEck Gold Miners ETF
GDX
$19B
| $6.29M | 2.23% | 185,000 +57,500 | +45% | +$1.95M |
|
8
Bank of America
BAC
$376B
| $6.19M | 2.19% | 150,000 | – | – |
|
9
argenx
ARGX
$43.6B
| $6.02M | 2.13% | 20,000 -4,000 | -17% | -$1.2M |
|
10
General Motors
GM
$55.8B
| $5.92M | 2.1% | 100,000 | – | – |
|
11
Verizon
VZ
$186B
| $5.6M | 1.99% | 100,000 +12,500 | +14% | +$700K |
|
12
Turning Point Brands
TPB
$1.79B
| $5.6M | 1.98% | 122,250 | – | – |
|
13
SPDR Gold Trust
GLD
$107B
| $5.38M | 1.91% | 32,500 -10,000 | -24% | -$1.66M |
|
14
Advanced Micro Devices
AMD
$264B
| $5.17M | 1.83% | 55,000 | – | – |
|
15
Incyte
INCY
$16.5B
| $5.13M | 1.82% | 61,000 -4,000 | -6% | -$337K |
|
|
16
Oracle
ORCL
$635B
| $4.87M | 1.72% | 62,500 -42,500 | -40% | -$3.31M |
|
17
Citigroup
C
$178B
| $4.6M | 1.63% | 65,000 | – | – |
|
|
18
iShares Gold Trust
IAU
$50.6B
| $3.37M | 1.19% | 100,000 -100,000 | -50% | -$3.37M |
|
|
KIN
19
DELISTED
Kindred Biosciences, Inc.
KIN
| $3.32M | 1.18% | 362,315 +161,315 | +80% | +$1.48M |
|
20
Prothena Corp
PRTA
$441M
| $3.18M | 1.13% | 61,750 +15,894 | +35% | +$817K |
|
21
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.97M | 1.05% | 17,500 -2,500 | -13% | -$424K |
|
|
AOD
22
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $2.75M | 0.97% | 270,000 -12,505 | -4% | -$127K |
|
23
Amgen
AMGN
$155B
| $2.74M | 0.97% | 11,250 | – | – |
|
24
Bristol-Myers Squibb
BMY
$96B
| $2.71M | 0.96% | 40,500 +500 | +1% | +$33.4K |
|
25
Eli Lilly
LLY
$657B
| $2.58M | 0.91% | 11,250 | – | – |
|